Mutation profiling in gallbladder cancer in Indian population

Indian Journal of Pathology and Microbiology

Volumn 57, Issue 1, 2014, Pages 9-12

  Kumari, Niraj ^a   Corless, Christopher L ^b   Warrick, Andrea ^b   Beadling, Carol ^c   Nelson, Dylan ^c   Neff, Tanay ^c   Krishnani, Narendra ^a   Kapoor, Vinay Kumar ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b Department of Surgical Pathology Histopathology and Shared Resource Pathology Translational Research Laboratory   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Gallbladder cancer; mutation profiling; sequenom mass array

Indexed keywords

K RAS PROTEIN; PROTEIN P53; BETA CATENIN; CTNNB1 PROTEIN, HUMAN; KRAS PROTEIN, HUMAN; ONCOPROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PIK3CA PROTEIN, HUMAN; RAS PROTEIN; TP53 PROTEIN, HUMAN;

ADENOCARCINOMA; ADENOSQUAMOUS CARCINOMA; ADULT; AGED; ARTICLE; CANCER SCREENING; CANCER THERAPY; EARLY DIAGNOSIS; FEMALE; GALLBLADDER CANCER; GALLSTONE; GENE MUTATION; HUMAN; HUMAN TISSUE; INDIAN; INFLAMMATION; LYMPH NODE METASTASIS; MALE; PATHOGENESIS; PERITONEUM METASTASIS; RETROSPECTIVE STUDY; GALLBLADDER TUMOR; GENETICS; INDIA; MIDDLE AGED; MUTATION; MUTATION RATE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BETA CATENIN; FEMALE; GALLBLADDER NEOPLASMS; HUMANS; INDIA; MALE; MIDDLE AGED; MUTATION; MUTATION RATE; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS; RAS PROTEINS; RETROSPECTIVE STUDIES; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84899422379     PISSN: 03774929     EISSN: 09745130     Source Type: Journal    
DOI: 10.4103/0377-4929.130849     Document Type: Article

References (11)

1. Abi-Rached B, Neugut AI. Diagnostic and management issues in gallbladder carcinoma. Oncology (Williston Park) 1995;9:19-24; discussion 24, 27, 30.
2. Henson DE, Albores-Saavedra J, Corle D. Carcinoma of the gallbladder. Histologic types, stage of disease, grade, and survival rates. Cancer 1992;70:1493-7.
3. Beadling C, Heinrich MC, Warrick A, Forbes EM, Nelson D, Justusson E, et al. Multiplex mutation screening by mass spectrometry evaluation of 820 cases from a personalized cancer medicine registry. J Mol Diagn 2011;13:504-13.
4. Deshpande V, Nduaguba A, Zimmerman SM, Kehoe SM, Macconaill LE, Lauwers GY, et al. Mutational profiling reveals PIK3CA mutations in gallbladder carcinoma. BMC Cancer 2011;11:60.
5. Kim YT, Kim J, Jang YH, Lee WJ, Ryu JK, Park YK, et al. Genetic alterations in gallbladder adenoma, dysplasia and carcinoma. Cancer Lett 2001;169:59-68.
6. Rashid A, Ueki T, Gao YT, Houlihan PS, Wallace C, Wang BS, et al. K-ras mutation, p53 overexpression, and microsatellite instability in biliary tract cancers: A population-based study in China. Clin Cancer Res 2002;8:3156-63.
7. Riener MO, Bawohl M, Clavien PA, Jochum W. Rare PIK3CA hotspot mutations in carcinomas of the biliary tract. Genes Chromosomes Cancer 2008;47:363-7.
8. Rashid A, Gao YT, Bhakta S, Shen MC, Wang BS, Deng J, et al. Beta-catenin mutations in biliary tract cancers: A population-based study in China. Cancer Res 2001;61:3406-9.
9. Yanagisawa N, Mikami T, Saegusa M, Okayasu I. More frequent beta-catenin exon 3 mutations in gallbladder adenomas than in carcinomas indicate different lineages. Cancer Res 2001;61:19-22.
10. Hanada K, Tsuchida A, Iwao T, Eguchi N, Sasaki T, Morinaka K, et al. Gene mutations of K-ras in gallbladder mucosae and gallbladder carcinoma with an anomalous junction of the pancreaticobiliary duct. Am J Gastroenterol 1999;94:1638-42.
11. Watanabe H, Date K, Itoi T, Matsubayashi H, Yokoyama N, Yamano M, et al. Histological and genetic changes in malignant transformation of gallbladder adenoma. Ann Oncol 1999;10(Suppl 4):136-9.